Eurofins Scientific SE (EPA:ERF)

Market Cap	11.26B
Revenue (ttm)	7.14B
Net Income (ttm)	382.30M
Shares Out	177.72M
EPS (ttm)	1.98
PE Ratio	31.92
Forward PE	15.62
Dividend	0.60 (0.95%)
Ex-Dividend Date	Apr 28, 2025

Volume	26,701
Average Volume	246,313
Open	63.26
Previous Close	63.36
Day's Range	63.00 - 64.30
52-Week Range	44.52 - 64.86
Beta	0.79
RSI	72.41
Earnings Date	Jul 23, 2025

About Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, training, advisory, and labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include susta...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1987
• Employees: 62,696
• Stock Exchange: Euronext Paris
• Ticker Symbol: ERF

Financial Performance

In 2024, Eurofins Scientific SE's revenue was 6.95 billion, an increase of 6.70% compared to the previous year's 6.51 billion. Earnings were 356.30 million, an increase of 38.91%.